DBV Technologies SA

DBV Technologies Announces Filing of 2020 Annual Report on Form 10-K and 2020 Universal Registration Document

17 Mar 2021 18:30:00 By Nasdaq GlobeNewswire

Monthly information regarding the total number of voting rights and total number of shares of the Company as of February 28, 2021

12 Mar 2021 16:30:00 By Nasdaq GlobeNewswire

DBV Technologies Reports Full-Year 2020 Financial Results and Recent Business Developments

11 Mar 2021 16:30:00 By Nasdaq GlobeNewswire

DBV Technologies to Participate in the H.C. Wainwright Global Life Sciences Conference

05 Mar 2021 16:30:00 By Nasdaq GlobeNewswire

DBV Technologies Announces Date Change for Reporting Full Year 2020 Financial Results

03 Mar 2021 18:00:00 By Nasdaq GlobeNewswire

DBV Technologies to Report Full Year 2020 Financial Results on March 4, 2021

01 Mar 2021 01:30:00 By Nasdaq GlobeNewswire

DBV Technologies to Participate in Upcoming AAAAI 2021 Congress

24 Feb 2021 01:30:00 By Nasdaq GlobeNewswire

DBV Technologies Announces Appointment of Michele F. Robertson as Chief Legal Officer

22 Feb 2021 01:30:00 By Nasdaq GlobeNewswire

DBV Technologies to Participate in SVB Leerink Global Partners Healthcare Conference

19 Feb 2021 01:30:00 By Nasdaq GlobeNewswire

Monthly information regarding the total number of voting rights and total number of shares of the Company as of January 31, 2021

11 Feb 2021 16:30:00 By Nasdaq GlobeNewswire

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

29 Jan 2021 16:30:00 By Nasdaq GlobeNewswire

DBV Technologies Provides Update on Investigational Viaskin™ Peanut for Children Ages 4-11 Years

14 Jan 2021 16:30:00 By Nasdaq GlobeNewswire

DBV Technologies Announces Change in U.S. Reporting Status and Final Approval of Global Restructuring Process

07 Jan 2021 01:30:00 By Nasdaq GlobeNewswire

Monthly information regarding the total number of voting rights and total number of shares of the Company as of December 31, 2020

05 Jan 2021 16:30:00 By Nasdaq GlobeNewswire